FOR IMMEDIATE RELEASE
Media Contacts:
Crocs , Inc. Introduces Newest Addition to CrocsRx™ Collection
Anaheim , Ca., June 19, 2008 – Today, CrocsRx™, the medical division of Crocs, Inc. (NASDAQ: CROX), revealed a new, sleeker addition to its therapeutic collection, the Silver Fox. Combining Crocs’ legendary comfort with fashion-forward sensibility, this classic mary jane style includes a 1½ inch heel. The new Silver Fox shoe, will be on display for doctors and medical professionals to view, along with the entire CrocsRx™ collection at Crocs booth #211 at The 2008 Western Podiatric Medical Congress show, June 19-22 in Anaheim, California.
Carrying both the distinguished United States ergonomics endorsement, as well as approval from the American Podiatric Medical Association (APMA), the Silver Fox is the first shoe in the collection to be designed specifically for a woman’s foot. Complete with Croslite AG+™ material, a revolutionary material created from nano-Silver ceramic crystals, the shoe is anti-bacterial and anti-fungal, thus killing harmful strains of bacteria and fungi which are routinely the source of foot infections. Additionally, the shock absorbing sole relieves stress on feet, knees, hips, and the lower back making it a sensible footwear choice for heel pain, arch pain and ultra sensitive feet. Offered in three sophisticated color combinations including bronze/brown, cotton candy/burgundy, and classic black/black, the Silver Fox (MSRP: $49.99) is available in women’s sizes 4-10.
“The addition of the Silver Fox is a prime example of our efforts to continually provide new and innovative footwear styles that incorporate our medical foot bed and our cutting edge CrosliteAg+™ material,” stated Eddie Scott, director of the CrocsRx™ Collection. “Just as our core collection continues to evolve, we’ve broadened our styles to appeal to a more diverse audience within the medical market.”
To learn more about CrocsRx™ footwear, or join the more than 3,000 doctors that either recommend shoes from the CrocsRx™ line to their patients or distribute CrocsRx™ models directly through their offices, visit www.crocsrx.com.
About Crocs, Inc:
Crocs, Inc. is a rapidly growing designer, manufacturer and retailer of footwear for men, women and children under the Crocs™ brand.
All Crocs™ brand shoes feature Crocs’ proprietary closed-cell resin, Croslite™, which represents a substantial innovation in footwear. The Croslite™ material enables us to produce soft, comfortable, lightweight, superior-gripping, non-marking and odor-resistant shoes. These unique elements make Crocs™ footwear ideal for casual wear, as well as for professional and recreational uses such as boating, hiking, hospitality and gardening. The versatile use of the material has enabled us to successfully market our products to a broad range of consumers.
The first footwear brand to receive the prestigious APMA Executive Director’s award and Company of the Year award from the Student Association of the APMA in a single year, CrocsRX™ is a leader in medical shoe sales with more than 3,000 doctors recommending or distributing the brand to patients. CrocsRX™ shoes are made from Crocs’ proprietary Croslite™ material and are designed to alleviate pain and discomfort from a variety of health related ailments. For more information, visit www.crocsrx.com.
Crocs™ shoes are sold in more than 90 countries and come in a wide array of colors and styles. Please visit www.crocs.com for additional information.